今、世界が注目する医学論文は?
<p><span style="font-family:'Noto Sans', -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';">インパクトファクターの高いジャーナルから、世界の研究者が注目する主に疾患に関する論文をご紹介します。</span></p>



今回は、①注意欠陥・多動性障害(ADHD)の治療薬を調査したランダム化比較試験(RCT)において盲検化の評価が行われているかどうかを評価した結果a)、②精神障害の診断・統計マニュアルであるDSM-IV、DSM-IV(TR)、DSM-5の各基準に基づき、ADHD症状の重症度における性差を評価した結果b)、③二重盲検RCTにより、多菌種プロバイオティクスサプリメントのADHDに対する効果を評価した結果c)、に関する以下の報告が注目を集めた。
(検索期間:2024年11月4日~11月17日まで)
-2025.3.31

今回は、①ASUC(Acute Severe Ulcerative colitis)における介入臨床試験の試験デザインに関して、コンセンサスを得た明確なポジションステートメントa)、②炎症性腸疾患(IBD)の症状プロファイルサブグループと心理的関連性を評価した結果b)、③潰瘍性大腸炎(UC)における糞便移植療法(FMT)による寛解導入の改善には、微生物レベルの厳格なドナーの予備選択、厳密な嫌気処理、FMTの反復投与が必要である、とする仮説の検証c)、に関する以下の報告が注目を集めた。
(検索期間:2024年12月20日~ 2025年1月10日まで)
‐2025.3.31

今回は、①狭窄性クローン病(CD)の管理に対する必須アミノ酸(EAA)および酪酸ナトリウム(NaB)による食事介入の有効性を評価した結果a)、②中等度から重度の潰瘍性大腸炎(UC)に対するビルベリー由来のアントシアニンリッチエキス(ACRE)の有効性を評価した結果b)、③炎症性腸疾患(IBD)に対する生物学的療法および低分子薬の効果を予測するバイオマーカーの同定c)、に関する以下の報告が注目を集めた。
(検索期間:2024年12月6日~12月19日まで)
-2025.3.31
2025.2.28 IBD
a) Partial Enteral Nutrition in the Management of Crohn’s Disease: A Systematic Review and Meta-Analysis
b) Preliminary results from a multicenter, randomized trial using fecal microbial transplantation to induce remission in patients with mild to moderate Crohn’s Disease
c) Telemonitoring of Active Inflammatory bowel disease Using the App TECCU: Short-Term Results of a Multicenter Trial of GETECCU
2025.2.27 IBD
a) Repeated endoscopic dilation and needle-knife stricturotomy for Crohn's disease strictures
b) A Core Outcome Set for Inflammatory Bowel Diseases: Development and Recommendations for Implementation in Clinical PracticeThrough an International Multistakeholder Consensus Process
c) Vascular endothelial growth factor in inflammatory bowel disease: A systematic review and meta-analysis
2025.1.31 IBD
a) Eosinophils and risk of ulcerative colitis in European population: Evidence from Mendelian randomization study
b) Therapeutic and Immunologic Effects of Short-Chain Fatty Acids in Inflammatory Bowel Disease: A Systematic Review
c) Mendelian randomization reveals predictive, preventive, and personalized insights into inflammatory bowel disease: the role of gut microbiome and circulating inflammatory proteins
2025.1.31 IBD
a) The association between bilirubin concentrations and inflammatory bowel disease: Insights from a systematic review and meta-analysis
b) Meta-analysis: Risk of lymphoma in patients with inflammatory bowel disease in population-based cohort studies
c) Gut Microbiota Features in Relation to Fecal Microbiota Transplantation Outcome in Ulcerative Colitis: A Systematic Review and Meta-Analysis
2024.12.24 IBD
a) Harms with placebo in trials of biological therapies and small molecules as induction therapy in inflammatory bowel disease: a systematic review and meta-analysis
b) Harms with placebo in trials of biological therapies and small molecules as maintenance therapy in inflammatory bowel disease: a systematic review and meta-analysis
c) Rates of Endoscopic Recurrence In Postoperative Crohn's Disease Based on Anastomotic Techniques: A Systematic Review And Meta-Analysis
2024.12.09 IBD
a) Comparing the Diagnostic Value of FDG PET or PET/CT with FDG PET/MR in Inflammatory Bowel Disease-A Systematic Review and Meta-analysis
b) The impact of group cognitive behavioral psychotherapy on disease severity and psychosocial functioning in patients with inflammatory bowel disease: a randomized controlled study
c) Oxidative stress-related biomarkers as promising indicators of inflammatory bowel disease activity: A systematic review and meta-analysis
2024.11.27 IBD
a) Chronic Kidney Disease in Inflammatory bowel disease: a Systematic Review and Meta-analysis
b) Prevalence of Sexual Dysfunction In Inflammatory bowel disease: Systematic Review and Meta-Analysis
c) Emerging role of environmental pollutants in Inflammatory bowel disease risk, outcomes and underlying mechanisms
2024.11.12 IBD
a) A global consensus on the definitions, diagnosis and management of fibrostenosing small bowel Crohn’s disease in clinical practice
b) Whole blood DNA methylation changes are associated with anti-TNF drug concentration in patients with Crohn's disease
c) Efficacy and safety of probiotics in IBD: An overview of systematic reviews and updated meta-analysis of randomized controlled trials
2024.10.21 IBD
a) Effect of mesenteric sparing or extended resection in primary ileocolic resection for Crohn's disease on postoperative endoscopic recurrence (SPICY): an international, randomised controlled trial
b) Systematic review: Patient-related, microbial, surgical, and histopathological risk factors for endoscopic post-operative recurrence in patients with Crohn's disease
c) Effect of hydrogel drug delivery system for treating ulcerative colitis: A preclinical meta-analysis
2024.10.04 IBD
a) Fungal Microbiota Composition in Inflammatory Bowel Disease Patients: Characterization in Different Phenotypes and Correlation With Clinical Activity and Disease Course
b) Single-Cell Transcriptomic and Targeted Genomic Profiling Adjusted for Inflammation and Therapy Bias Reveal CRTAM and PLCB1 as Novel Hub Genes for Anti-Tumor Necrosis Factor Alpha Therapy Response in Crohn’s Disease
c) Early Biologic Treatment Decreases Risk of Surgery in Crohn’s Disease but not in Ulcerative Colitis: Systematic Review and Meta-Analysis